Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Kevin Hrusovsky, Nicolas Barthelemy


Quanterix has named Kevin Hrusovsky executive chairman of its board of directors.
Hrusovsky will replace Martin Madaus, who gave up his chairman seat to be chairman and CEO of Ortho-Clinical Diagnostics but who will remain on the Quanterix board.

Hrusovsky formerly was president of PerkinElmer Life Sciences & Technology. He was CEO of Caliper Life Sciences and joined PerkinElmer after that firm acquired Caliper in 2011 for $600 million. Hrusovsky also previously served as CEO of Zymark, and he was president of FMC Corporation's Pharmaceuticals and International Agricultural Products.

Repligen has appointed Nicolas Barthelemy to its board of directors. He spent the last nine years at Life Technologies, until Thermo Fisher Scientific acquired it, most recently serving as Life Tech's president of global commercial operations. Prior to joining Life Tech, he was vice president of manufacturing at Biogen and also the general manager for the company's manufacturing organization.